These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 3026777

  • 1. Parathyroid hormone-like adenylate cyclase-stimulating activity from a human carcinoma is associated with bone-resorbing activity.
    Klein RF, Strewler GJ, Leung SC, Nissenson RA.
    Endocrinology; 1987 Feb; 120(2):504-11. PubMed ID: 3026777
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Two species of adenylate cyclase-stimulating activity in a murine squamous carcinoma model of humoral hypercalcemia of malignancy.
    Burtis WJ, Broadus AE, Insogna KL, Weir EC, Stewart AF.
    Endocrinology; 1986 May; 118(5):1982-8. PubMed ID: 3009144
    [Abstract] [Full Text] [Related]

  • 4. Co-purification of transforming growth factor beta-like activity with PTH-like and bone-resorbing activities from a tumor associated with humoral hypercalcemia of malignancy.
    Insogna KL, Weir EC, Wu TL, Stewart AF, Broadus AE, Burtis WJ, Centrella M.
    Endocrinology; 1987 May; 120(5):2183-5. PubMed ID: 3494596
    [Abstract] [Full Text] [Related]

  • 5. Bone and kidney adenylate cyclase-stimulating activity produced by a hypercalcemic canine adenocarcinoma line (CAC-8) maintained in nude mice.
    Rosol TJ, Capen CC, Brooks CL.
    Cancer Res; 1987 Feb 01; 47(3):690-5. PubMed ID: 3467838
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Activation of the parathyroid hormone receptor-adenylate cyclase system in osteosarcoma cells by a human renal carcinoma factor.
    Nissenson RA, Strewler GJ, Williams RD, Leung SC.
    Cancer Res; 1985 Nov 01; 45(11 Pt 1):5358-63. PubMed ID: 2996759
    [Abstract] [Full Text] [Related]

  • 9. Osteolytic activity of Walker carcinosarcoma 256 is due to parathyroid hormone-related protein (PTHrP).
    Scharla SH, Minne HW, Lempert UG, Krieg P, Rappel S, Maurer E, Grohe U, Ziegler R.
    Horm Metab Res; 1991 Feb 01; 23(2):66-9. PubMed ID: 1646150
    [Abstract] [Full Text] [Related]

  • 10. Frequency and partial characterization of adenylate cyclase-stimulating activity in tumors associated with humoral hypercalcemia of malignancy.
    Stewart AF, Insogna KL, Burtis WJ, Aminiafshar A, Wu T, Weir EC, Broadus AE.
    J Bone Miner Res; 1986 Jun 01; 1(3):267-76. PubMed ID: 2845726
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Inhibition of in vitro bone resorption by a parathyroid hormone receptor antagonist in the canine adenocarcinoma model of humoral hypercalcemia of malignancy.
    Rosol TJ, Capen CC.
    Endocrinology; 1988 May 01; 122(5):2098-102. PubMed ID: 2834184
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.